Navigation Links
Notre Dame researchers scoring a win-win with novel set of concussion diagnostic tools
Date:3/26/2013

From Junior Seau, former San Diego Chargers linebacker, to Dave Duerson, former Chicago Bears safety who both committed suicide as a result of chronic traumatic encephalopathy (CTE), traumatic brain injuries (TBIs) have been making gruesome headlines at an alarming rate. In the United States alone, TBIs account for an estimated 1.6 - 3.8 million sports injuries every year, with approximately 300,000 of those being diagnosed among young, nonprofessional athletes. But TBIs are not confined to sports; they are also considered a signature wound among soldiers of the Iraq and Afghanistan wars.

The potential impact on the health and well-being of individuals with brain injuries are numerous. These individuals might display a range of symptoms such as headaches, depression, loss of memory and loss of brain function which may persist for weeks or months. The effects of brain injuries are most devastating when they remain unrecognized for long periods of time. This is where Christian Poellabauer, associate professor of computer science and engineering; Patrick Flynn, professor of computer science and engineering; Nikhil Yadav, graduate student of computer science and engineering; and a team of students and faculty are making their own impact.

Although baseline tests of athletes prior to an injury are trending up, these tests must still be compared to examinations after an injury has occurred. They require heavy medical equipment, such as a CT scanner, MRI equipment, or X-ray machine, and are not always conclusive. The Notre Dame team has developed a tablet-based testing system that captures the voice of an individual and analyzes the speech for signs of a potential concussion anytime, anywhere, in real-time.

"This project is a great example of how mobile computing and sensing technologies can transform healthcare," Poellabauer said. "More important, because almost 90 percent of concussions go unrecognized, this technology offers tremendous potential to reduce the impact of concussive and sub-concussive hits to the head."

The system sounds simple enough: an individual speaks into a SmartPhone equipped with the Notre Dame program before and after an event. The two samples are then compared for TBI indicators, which include distorted vowels, hyper nasality and imprecise consonants.

Notre Dame's system offers a variety of advantages over traditional testing, such as portability, high accuracy, low cost and a low probability of manipulation (the results cannot be faked); it has also proven very successful. In testing which occurred during the Notre Dame's Bengal Bouts and Baraka Bouts, annual student boxing tournaments, the researchers established baselines for boxers using tests such as the Axon Sports Computerized Cognitive Assessment Tool (CCAT), the Sport Concussion Assessment Tool 2 (SCAT2), and the Notre Dame iPad-based reading and voice recording test.

During the 2012 Bengal Bouts nine concussions (out of 125 participants) were confirmed by this new speech based test and the University's medical team. Separate tests of 80 female boxers were also conducted during the 2012 Baraka Bouts. Outcomes of the 2013 Bengal Bouts are currently being compared to the findings of the University medical team on approximately 130 male boxers.

The testing was done in cooperation with James Moriarity, the University's chief sports medicine physician, who has developed a series of innovative concussion testing studies.


'/>"/>

Contact: Christian Poellabauer
cpoellab@nd.edu
574-631-9131
University of Notre Dame
Source:Eurekalert

Related medicine news :

1. Notre Dame researchers paper examines the biology of tumor-derived microvesicles
2. Nanoparticles engineered at Notre Dame promise to improve blood cancer treatment
3. Researchers form new nerve cells &#8211 directly in the brain
4. Moffitt Cancer Center researchers design small molecule to disrupt cancer-causing protein
5. UW researchers discover the brain origins of variation in pathological anxiety
6. Researchers decode biology of blood and iron disorders mapping out novel future therapies
7. Researchers developing antiviral drug to combat contagious norovirus
8. WSU researchers to study effect of fatigue on attention
9. Patient Wishes Should Guide End-of-Life Care, Researchers Say
10. Researchers new method may sharpen microscopic images
11. Researchers tackle physician challenge of correctly ordering laboratory tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... It’s no secret that aging ... to a host of health issues, including urinary incontinence. However, results published in ... that good overall muscle strength in older women, particularly in the abdominal and ...
(Date:2/27/2017)... ... , ... The threat of nuclear warfare has long plagued this world. In ... underground testing of nuclear weapons. Years later, when her co-workers began dying, Dot started ... Nuclear Testing,” Clayton exposes the critical decisions made by agencies involved in the nuclear ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... POUGHKEEPSIE, N. ... ) has disclosed that despite scientific studies, the Center for Disease Control ( CDC ... Lyme disease . Kenneth B. Liegner, M.D. has compiled into a single volume ...
(Date:2/27/2017)... ... February 27, 2017 , ... New Jersey ranks among the top ... and genders. And the need for advanced services is growing. , Project WE ... care program, in collaboration with their non-profit partners in their fight against cancer and ...
(Date:2/26/2017)... New York, New York (PRWEB) , ... February ... ... of luxury baby products for wholesale distribution in North America, today announced it ... established online sites. The company, which prides itself on crafting quality and unique ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... Israel and TAMPA, Fla. , Feb. ... emerging medical device company focused on developing cerebral ... applauds the members of the FDA,s Circulatory System ... their acknowledgement of the need for cerebral protection ... "The statements shared by this FDA panel ...
(Date:2/27/2017)... Md. , Feb. 27, 2017  RegeneRx ... a clinical-stage drug development company focused on tissue ... licensee for RGN-137, GtreeBNT Co., Ltd., received a ... Phase 3 clinical trial design for RGN-137 to ... wound healing gel that incorporates Thymosin beta 4 ...
(Date:2/27/2017)... 27, 2017 A recent research report published ... market alone is expected to reach a value of $55.8 billion ... along with 28 states have legalized marijuana for medical uses. In ... Florida , North Dakota , ... to use the drug in medical applications such as chemotherapies and ...
Breaking Medicine Technology: